Helpful Interstitial Cystitis Resources

Managing a chronic condition like interstitial cystitis (IC) is a learning process, but it can be done. And whether it’s through a local IC group, one of our e-mail support programs or a printable tip sheet, there are many ways to get additional help.

IC Information E-mails
Not sure if you have IC? Sign up for e-mails that will help you learn more about IC and its symptoms.

User Support Program—Journey to Relief ^®
Maximize the success of your ELMIRON^® therapy with this helpful e-newsletter series that provides additional advice and resources especially for new users of ELMIRON^®.

IC Support Links
Visit some other Web sites dedicated to IC support and education.

IC Downloads
Get additional printable materials about IC and managing IC symptoms.

Glossary
Find the definitions of some common terms associated with IC.

Find a Doctor
Find a doctor in your area who is familiar with IC.

Prescription Drug Coverage Assistance
If you don't have prescription drug coverage, find out more about assistance programs that could provide discounted or free prescriptions at www.access2wellness.com. Access2wellness™ provides access to more than 1,000 free and discounted prescription medications for uninsured and underinsured individuals who qualify.

NEXT: IC Support Links

ELMIRON^® is indicated for the relief of bladder pain or discomfort associated with interstitial cystitis.
ELMIRON^® is available by prescription only.

IMPORTANT SAFETY INFORMATION

ELMIRON^® is a weak anticoagulant (blood thinner) which may increase bleeding. Call your doctor if you will be undergoing surgery or will begin taking anticoagulant therapy such as warfarin, heparin, high doses of aspirin, or anti-inflammatory drugs such as ibuprofen.

ELMIRON^® should not be taken if you have a known hypersensitivity to the drug or similar drugs.

The most common side effects observed in clinical trials were blood in stool, diarrhea, nausea, hair loss, headache, rash, upset stomach, abdominal pain, liver function abnormalities, and dizziness. Hair loss, when it occurred, was almost always limited to a single area of the scalp, and grew back when ELMIRON^® was discontinued.

The mechanism of action of ELMIRON^® in interstitial cystitis is not fully understood.

Please see full Product Information for ELMIRON^®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2009. All rights reserved. Your use of the information on this site is subject to the terms of our Legal Notice. This site is published by Ortho Women's Health & Urology™, Division of Ortho-McNeil-Janssen

ELMIRON^® is a registered trademark of IVAX Research, Inc, under license to Ortho-McNeil-Janssen Pharmaceuticals, Inc.

This information is intended for use by our customers, patients and healthcare professionals in the United States only. Ortho Women's Health & Urology™ recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Full Product Information included here may not be appropriate for use outside the United States.
Last modified November 12, 2009